|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/50 |
| (11) | Number of the document | 3265808 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16707785.8 |
| Date of filing the European patent application | 2016-03-03 | |
| (97) | Date of publication of the European application | 2018-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/054552 |
| Date | 2016-03-03 |
| (87) | Number | WO 2016/139308 |
| Date | 2016-09-09 |
| (30) | Number | Date | Country code |
| 15157549 | 2015-03-04 | EP |
| (72) |
JATZKE, Claudia, DE
EISELE, Karl-Heinz, DE
MANDER, Gerd, DE
FINK, Klaus, DE
|
| (73) |
Merz Pharma GmbH & Co. KGaA,
Eckenheimer Landstrasse 100, 60318 Frankfurt am Main,
DE
|
| (54) | METHODS FOR ENHANCING THE SPECIFIC UPTAKE OF BOTULINUM NEUROTOXINS INTO CELLS |
| METHODS FOR ENHANCING THE SPECIFIC UPTAKE OF BOTULINUM NEUROTOXINS INTO CELLS |